title: In vitro effects of RU486 on proliferation and differentiation capabilities of human bone marrow mesenchymal stromal cells.
abstract: Although exogenous glucocorticoids (GC) play a role in the regulation of bone marrow mesenchymal stem/stromal cells (MSCs) proliferation and differentiation, the function of endogenous GC is not well understood. The purpose of this study was to investigate the effect of the blockage of endogenous GC using RU486, an antagonist of the glucocorticoid receptor, on the in vitro proliferation and differentiation capabilities of human MSCs. We quantitatively measured cell proliferation of human MSCs after treatment with increasing concentrations of RU486. We also evaluated multiple MSC differentiation capabilities, as well as the expression of stemness and senescence genes after proliferation of these human cells in vitro in the presence of RU486 at 10(-8)M. It was observed that RU486 treatment significantly increases the proliferation of human MSCs, although the optimal dose of RU486 for this increase in proliferation differs depending on the gender of the MSC donor. This improvement in MSC proliferation with RU486 treatment was higher in MSCs from male donors than that from females. No effect of RU486 on MSC proliferation was observed in a steroid-free medium. RU486 pretreatment significantly increased the expression of mRNA for alkaline phosphatase in human MSCs and the mRNA expression of osteocalcin of these cells up-regulated earlier after their exposure to osteogenic differentiation medium. Although no statistical significance in terms of chondrogenic differentiation markers was detected, mRNA expression for aggrecan and collagen type 2 were higher in a majority of the RU486-pretreated donor MSCs than their untreated controls. No significant difference in terms of MSC adipogenic differentiation capabilities were observed after RU486 treatment. RU486 treatment up-regulated the expressions of FGF-2 and Sox-11 in human MSCs. These results indicate that blockage of endogenous GCs may be developed as a novel approach to effectively improve the proliferation and osteochondral differentiation capabilities of human MSCs for potential clinical applications. Additional studies will be required to determine the potential long-term effects of RU486 treatment on these bone marrow cells.
authors.affiliation: Dows Institute for Dental Research, College of Dentistry, University of Iowa, Iowa City, IA 52242, USA.
authors.forename: Yang
authors.initials: Y
authors.lastname: Yu
authors.forename: Na
authors.initials: N
authors.lastname: Wei
authors.forename: Clark
authors.initials: C
authors.lastname: Stanford
authors.forename: Thomas
authors.initials: T
authors.lastname: Schmidt
authors.forename: Liu
authors.initials: L
authors.lastname: Hong
mesh_terms: D000328:Adult; D053674:Aggrecans / Q000096:biosynthesis; D000469:Alkaline Phosphatase / Q000096:biosynthesis; D001854:Bone Marrow Cells / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D002454:Cell Differentiation / Q000187:drug effects*; D049109:Cell Proliferation / Q000187:drug effects*; D002478:Cells, Cultured; D024043:Collagen Type II / Q000096:biosynthesis; D004305:Dose-Response Relationship, Drug; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000096:biosynthesis; D006801:Humans; D008297:Male; D059630:Mesenchymal Stem Cells / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D008875:Middle Aged; D015735:Mifepristone / Q000494:pharmacology*; D015675:Osteocalcin / Q000096:biosynthesis; D010012:Osteogenesis; D011965:Receptors, Glucocorticoid / Q000037:antagonists & inhibitors* / Q000378:metabolism; D012737:Sex Factors
chemical_list: D053674:Aggrecans; D024043:Collagen Type II; D011965:Receptors, Glucocorticoid; D016222:Fibroblast Growth Factor 2; D015675:Osteocalcin; D015735:Mifepristone; D000469:Alkaline Phosphatase
references.citation: Int J Biochem Cell Biol. 2004 Apr;36(4):568-84
references.pmid: 15010324
references.citation: Depress Anxiety. 2010 Apr;27(4):327-38
references.pmid: 20376837
references.citation: J Psychiatry Neurosci. 2005 Sep;30(5):328-34
references.pmid: 16151537
references.citation: J Steroid Biochem Mol Biol. 1998 Jul;66(1-2):11-25
references.pmid: 9712407
references.citation: Genes Cells. 2009 Mar;14(3):407-24
references.pmid: 19228201
references.citation: J Tissue Eng Regen Med. 2010 Jul;4(5):374-86
references.pmid: 20058244
references.citation: Arthritis Res Ther. 2007;9(1):204
references.pmid: 17316462
references.citation: J Cell Physiol. 2005 Nov;205(2):194-201
references.pmid: 15880640
references.citation: Biochim Biophys Acta. 2009 Apr;1792(4):364-70
references.pmid: 19419706
references.citation: Surgery. 2007 Aug;142(2):215-21
references.pmid: 17689688
references.citation: EMBO J. 1997 Jan 15;16(2):267-80
references.pmid: 9029148
references.citation: Aging Cell. 2004 Dec;3(6):379-89
references.pmid: 15569355
references.citation: J Cell Biochem. 2004 Jul 1;92(4):745-54
references.pmid: 15211572
references.citation: QJM. 2005 Mar;98(3):191-8
references.pmid: 15728400
references.citation: Exp Mol Pathol. 2003 Oct;75(2):178-86
references.pmid: 14516782
references.citation: Tissue Eng. 2006 Oct;12(10):2747-53
references.pmid: 17518644
references.citation: Cancer Res. 1994 Jun 15;54(12):3088-91
references.pmid: 7911394
references.citation: J Cell Biochem. 2001;82(4):583-90
references.pmid: 11500936
references.citation: Science. 1999 Apr 2;284(5411):143-7
references.pmid: 10102814
references.citation: Tissue Eng. 2005 May-Jun;11(5-6):787-802
references.pmid: 15998219
references.citation: J Cell Mol Med. 2004 Jul-Sep;8(3):301-16
references.pmid: 15491506
references.citation: J Bone Miner Res. 1997 Oct;12(10):1606-14
references.pmid: 9333121
references.citation: Biochem Biophys Res Commun. 2007 Jul 20;359(1):108-14
references.pmid: 17532297
references.citation: Exp Cell Res. 2008 Jun 10;314(9):1937-44
references.pmid: 18439579
references.citation: Tissue Eng Part C Methods. 2010 Dec;16(6):1407-15
references.pmid: 20373975
references.citation: Crit Rev Eukaryot Gene Expr. 2008;18(2):173-88
references.pmid: 18304031
references.citation: Tissue Eng Part A. 2010 Nov;16(11):3385-94
references.pmid: 20626275
references.citation: J Endocrinol. 1999 Sep;162(3):371-9
references.pmid: 10467228
references.citation: Endocr Res. 2002 Nov;28(4):709-18
references.pmid: 12530687
references.citation: J Cell Biochem. 2000 Sep 14;79(4):557-65
references.pmid: 10996846